Literature DB >> 91580

Prophylactin utility of human gammaglobulin for protection against bacterial infections among low birth weight babies.

M Singh, S Manerikar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91580     DOI: 10.1007/BF02896748

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  9 in total

1.  The effect of monthly gamma-globulin administration on morbidity and mortality from infection in premature infants during the first year of life.

Authors:  J AMER; E OTT; F A IBBOTT; D O'BRIEN; C H KEMPE
Journal:  Pediatrics       Date:  1963-07       Impact factor: 7.124

2.  Transient 19S gammaglobulin deficiency in the newborn infant, and its significance.

Authors:  D GITLIN; F S ROSEN; J G MICHAEL
Journal:  Pediatrics       Date:  1963-02       Impact factor: 7.124

Review 3.  Neonatal immunity.

Authors:  S P Gotoff
Journal:  J Pediatr       Date:  1974-08       Impact factor: 4.406

Review 4.  Sepsis neonatorum.

Authors:  H D Wilson; H F Eichenwald
Journal:  Pediatr Clin North Am       Date:  1974-08       Impact factor: 3.278

5.  Human immunoglobulins--a guide to nomenclature and clinical application.

Authors:  R T Smith
Journal:  Pediatrics       Date:  1966-05       Impact factor: 7.124

6.  Serum gamma-G-globulin levels and gestational age in premature babies.

Authors:  J R Hobbs; J A Davis
Journal:  Lancet       Date:  1967-04-08       Impact factor: 79.321

7.  Deficient serum opsonic activity for macrophage function in newborn infants.

Authors:  C W Graham; T M Saba; S Lolekha; S P Gotoff
Journal:  Proc Soc Exp Biol Med       Date:  1973-09

8.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

9.  Antibodies against gamma-globulin after repeated blood transfusions in man.

Authors:  J C Allen; H G Kunkel
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.